Multiple Myeloma: International Myeloma Foundation : • media   : archive : THE IMF SAYS NEWLY DIAGNOSED PATIENTS COULD BENEFIT FROM FDA "PRIORITY REVIEW" OF VELCADE® FOR FRONT-LINE USE

We are international

media contact

archive

back

THE IMF SAYS NEWLY DIAGNOSED PATIENTS COULD BENEFIT FROM FDA "PRIORITY REVIEW" OF VELCADE® FOR FRONT-LINE USE

Priority review puts VELCADE on track for potential approval in mid-2008

	02.04.08
Be the first to comment Name Email Address URL Remember personal info? Comments (You may use HTML tags for style)	print share \| related articles

Be the first to comment